Skip to main content
Grey Wolf Animal Health Corp. logo

Grey Wolf Animal Health Corp. — Investor Relations & Filings

Ticker · WOLF ISIN · CA3978851044 TSXV Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2026-05-22 Proxy Solicitation & In…
Country CA Canada
Listing TSXV WOLF

About Grey Wolf Animal Health Corp.

https://greywolfah.com/

Grey Wolf Animal Health Corp. is a specialty animal health and wellness company focused on improving the lives and well-being of animals, including pets and horses, by empowering veterinary professionals and owners with innovative solutions. The company operates in the animal health market, developing and commercializing products that address unmet needs. Key offerings include prescription injectables (such as Ataject™ and Sedaject™), advanced wound care products (like Activon® Tube, featuring medical-grade Manuka Honey), all-natural gastrointestinal treatments (GI™ Portfolio), and vet-exclusive nutraceuticals (Composure™ Pro). Furthermore, through its compounding pharmacy, Trutina, the company provides specialized custom formulations, particularly for the equine market.

Recent filings

Filing Released Lang Actions
Other.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Voting Instruction Form (VIF) soliciting proxy votes for the Annual General and Special Meeting, including voting guidelines, resolutions, and proxy appointment details. This is a proxy solicitation material sent to shareholders to request their votes. It is not the meeting results or the full report itself, but the information used to solicit votes, fitting the definition of a Proxy Solicitation & Information Statement.
2026-05-22 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release dated May 21, 2026 from Grey Wolf Animal Health Corp. announcing its first quarter 2026 financial results (revenue, gross profit, EBITDA, net income, etc.) and providing key highlights and summary tables. It is not the full interim report filed with regulators but is an initial earnings announcement. This matches the “Earnings Release” category (ER). Q1 2026
2026-05-21 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 91% confidence The document is a certificate by the CEO attesting to the accuracy and fair presentation of interim filings (the interim financial report and interim MD&A) under Canadian NI 52-109. It contains no substantive financial data or analysis itself and is an officer certification letter. Under the “CERTIFICATION RULE,” such attestations are classified as Regulatory Filings (RNS), not as the interim report itself.
2026-05-21 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled “Interim Condensed Consolidated Financial Statements” for the three-month period ended March 31, 2026. It contains complete interim financial statements (balance sheet, income statement, cash flows, equity changes) and accompanying notes prepared under IFRS Accounting Standard IAS 34. It is substantive interim/quarterly financial reporting rather than an announcement or summary. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-21 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release dated April 16, 2026 announcing fourth quarter and full-year 2025 financial results, including key highlights, summary tables of revenue, EBITDA, and net income, as well as brief commentary from the CEO. It is not the full management discussion and analysis or audited financial statements but rather the initial earnings announcement for the period. Therefore, it matches the Earnings Release category (ER). FY 2025
2026-04-17 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release announcing the company’s financial results for the fourth quarter and full fiscal year ended December 31, 2025. It includes key highlights, summary tables of revenue, profit, EBITDA and basic discussion of operations, typical of an initial earnings announcement rather than a full interim/quarterly report (IR) or an annual report (10-K). Therefore, this fits the Earnings Release category. FY 2025
2026-04-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.